Antisense Therapeutics Limited (AU:PER) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics Limited has announced the issue of 8,400,000 unquoted options expiring on July 4, 2029, at an exercise price of $0.083 each. The options, which are part of an employee incentive scheme, were issued on July 4, 2024, and are not intended to be quoted on the ASX.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.